66
Participants
Start Date
July 31, 2009
Primary Completion Date
March 31, 2010
Study Completion Date
March 31, 2010
Placebo
Placebo
Experimental paracetamol + caffeine formulation
experimental paracetamol + caffeine formulation
ibuprofen marketed formulation
ibuprofen marketed formulation
Paracetamol marketed formulation
Paracetamol marketed formulation
Elkind Headache Center, Mount Vernon
International Research Service, Inc., Port Chester
Biomedical Research Alliance of New York LLC, Lake Success
Jefferson Headache Center, Philadelphia
University Clinical Research, Inc., Pembroke Pines
Springfield Neurology Associates, Springfield
MedVadis Research Corporation, Wellesley Hills
Lead Sponsor
GlaxoSmithKline
INDUSTRY